Display options
Share it on

Front Microbiol. 2015 Nov 26;6:1316. doi: 10.3389/fmicb.2015.01316. eCollection 2015.

Investigation of Antioxidative and Anticancer Potentials of Streptomyces sp. MUM256 Isolated from Malaysia Mangrove Soil.

Frontiers in microbiology

Loh Teng-Hern Tan, Hooi-Leng Ser, Wai-Fong Yin, Kok-Gan Chan, Learn-Han Lee, Bey-Hing Goh

Affiliations

  1. Biomedical Research Laboratory, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia Bandar Sunway, Malaysia.
  2. Division of Genetics and Molecular Biology, Institute of Biological Sciences, Faculty of Science, University of Malaya Kuala Lumpur, Malaysia.

PMID: 26635777 PMCID: PMC4659911 DOI: 10.3389/fmicb.2015.01316

Abstract

A Streptomyces strain, MUM256 was isolated from Tanjung Lumpur mangrove soil in Malaysia. Characterization of the strain showed that it has properties consistent with those of the members of the genus Streptomyces. In order to explore the potential bioactivities, extract of the fermented broth culture of MUM256 was prepared with organic solvent extraction method. DPPH and SOD activity were utilized to examine the antioxidant capacity and the results have revealed the potency of MUM256 in superoxide anion scavenging activity in dose-dependent manner. The cytotoxicity of MUM256 extract was determined using cell viability assay against 8 different panels of human cancer cell lines. Among all the tested cancer cells, HCT116 was the most sensitive toward the extract treatment. At the highest concentration of tested extract, the result showed 2.3-, 2.0-, and 1.8-folds higher inhibitory effect against HCT116, HT29, and Caco-2 respectively when compared to normal cell line. This result has demonstrated that MUM256 extract was selectively cytotoxic toward colon cancer cell lines. In order to determine the constituents responsible for its bioactivities, the extract was then subjected to chemical analysis using GC-MS. The analysis resulted in the identification of chemical constituents including phenolic and pyrrolopyrazine compounds which may responsible for antioxidant and anticancer activities observed. Based on the findings of this study, the presence of bioactive constituents in MUM256 extract could be a potential source for the development of antioxidative and chemopreventive agents.

Keywords: Malaysia; Streptomyces sp.; anticancer; antioxidant; mangrove

References

  1. Clin Cancer Res. 1999 Oct;5(10):2908-17 - PubMed
  2. Chem Biol. 2000 Jun;7(6):395-403 - PubMed
  3. Chem Biol. 2000 Aug;7(8):623-42 - PubMed
  4. Naturwissenschaften. 2002 Jan;89(1):23-30 - PubMed
  5. Int J Syst Evol Microbiol. 2003 Mar;53(Pt 2):479-84 - PubMed
  6. Nature. 1964 May 30;202:928-9 - PubMed
  7. J Antibiot (Tokyo). 2005 Jan;58(1):1-26 - PubMed
  8. J Assoc Physicians India. 2004 Oct;52:794-804 - PubMed
  9. Clin Orthop Relat Res. 2005 Aug;(437):3-6 - PubMed
  10. Chem Biol Interact. 2006 Mar 10;160(1):1-40 - PubMed
  11. J Bacteriol. 1943 Oct;46(4):337-41 - PubMed
  12. Biotechnol Appl Biochem. 2006 Jun;44(Pt 3):135-42 - PubMed
  13. Int J Syst Evol Microbiol. 2009 Mar;59(Pt 3):472-6 - PubMed
  14. Mar Drugs. 2009;7(1):24-44 - PubMed
  15. Plant Signal Behav. 2008 Mar;3(3):156-65 - PubMed
  16. Int J Syst Evol Microbiol. 2009 Oct;59(Pt 10):2624-8 - PubMed
  17. Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1893-907 - PubMed
  18. Int J Syst Evol Microbiol. 2011 Jul;61(Pt 7):1632-7 - PubMed
  19. Molecules. 2010 Dec 15;15(12):9298-307 - PubMed
  20. Int J Syst Evol Microbiol. 2012 Mar;62(Pt 3):596-600 - PubMed
  21. Int J Syst Evol Microbiol. 2012 Mar;62(Pt 3):716-21 - PubMed
  22. J Nat Med. 2012 Jul;66(3):544-51 - PubMed
  23. Org Lett. 2012 May 4;14(9):2422-5 - PubMed
  24. Anticancer Agents Med Chem. 2012 Dec;12(10):1281-305 - PubMed
  25. World J Microbiol Biotechnol. 2012 May;28(5):2125-37 - PubMed
  26. BMC Complement Altern Med. 2012 Aug 17;12:128 - PubMed
  27. Mar Drugs. 2013 Mar 12;11(3):817-29 - PubMed
  28. Asian Pac J Trop Med. 2013 Apr 13;6(4):325-32 - PubMed
  29. BMC Microbiol. 2013 Jun 22;13:145 - PubMed
  30. Mol Biol Evol. 2013 Dec;30(12):2725-9 - PubMed
  31. World J Microbiol Biotechnol. 1996 Jan;12(1):82-4 - PubMed
  32. Int J Syst Evol Microbiol. 2014 May;64(Pt 5):1461-7 - PubMed
  33. Mar Drugs. 2014 Feb 13;12(2):899-925 - PubMed
  34. Gastrointest Cancer Res. 2014 Jan;7(1):23-6 - PubMed
  35. J Young Pharm. 2013 Dec;5(4):121-6 - PubMed
  36. J Ethnopharmacol. 2014 Apr 28;153(2):375-85 - PubMed
  37. Int J Syst Evol Microbiol. 2014 Sep;64(Pt 9):3297-306 - PubMed
  38. ScientificWorldJournal. 2014;2014:698178 - PubMed
  39. Asian Pac J Trop Med. 2014 Dec;7(12):962-7 - PubMed
  40. CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29 - PubMed
  41. Int J Mol Cell Med. 2014 Fall;3(4):246-54 - PubMed
  42. Antonie Van Leeuwenhoek. 2015 Jun;107(6):1369-78 - PubMed
  43. Front Oncol. 2015 May 11;5:105 - PubMed
  44. Evid Based Complement Alternat Med. 2015;2015:896314 - PubMed
  45. Front Microbiol. 2015 Aug 20;6:854 - PubMed
  46. Evolution. 1985 Jul;39(4):783-791 - PubMed
  47. Food Addit Contam. 1989 Apr-Jun;6(2):201-7 - PubMed
  48. Mol Biol Evol. 1987 Jul;4(4):406-25 - PubMed
  49. Br J Cancer. 1987 Sep;56(3):279-85 - PubMed
  50. J Bacteriol. 1985 Oct;164(1):425-33 - PubMed
  51. J Mol Evol. 1981;17(6):368-76 - PubMed
  52. J Mol Evol. 1980 Dec;16(2):111-20 - PubMed
  53. Drugs. 1995 Mar;49(3):345-61 - PubMed
  54. Gene. 1994 Dec 30;151(1-2):1-10 - PubMed
  55. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7915-22 - PubMed
  56. Chem Res Toxicol. 1997 May;10(5):485-94 - PubMed
  57. Nucleic Acids Res. 1997 Dec 15;25(24):4876-82 - PubMed

Publication Types